REPONEX PHARMACEUTICALS A/S: Financial statements 2015
CVR: 30082346
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
REPONEX PHARMACEUTICALS A/S (CVR 30082346) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -1,182,333 and a net result of DKK -933,677 compared with DKK -682,835 the year before. Equity in the 2015 report amounted to DKK 535,511. The solvency ratio was 18.5%.
- Gross Profit
- DKK -1,182,333
- Profit/Loss
- DKK -933,677
- Equity
- DKK 535,511
- Total Assets
- DKK 2,894,973
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -1.2 mio. | -934 t. | 536 t. | - |
| 2014 | 1 | -34 t. | -683 t. | 1.5 mio. | - |
| 2013 | - | - | 150 t. | 230 t. | - |
| 2012 | - | - | -18 t. | 80 t. | - |
Official annual report
How creditworthy is REPONEX PHARMACEUTICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of October 30, 2015, Jacob Rosenberg has left the board of directors of REPONEX PHARMACEUTICALS A/S.
REPONEX PHARMACEUTICALS A/S has published its annual report for 2014. Revenue came to DKK 1, and the net result was DKK -682,835.
As of March 17, 2015, Troels Peter Troelsen has joined the board of directors of REPONEX PHARMACEUTICALS A/S.
As of March 17, 2015, Jacob Rosenberg has joined the board of directors of REPONEX PHARMACEUTICALS A/S.
As of March 17, 2015, Henrik Bulskov has joined the board of directors of REPONEX PHARMACEUTICALS A/S.
About REPONEX PHARMACEUTICALS A/S
REPONEX PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPONEX PHARMACEUTICALS ApS and TRIFOILIUM ApS. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Troels Peter Troelsen and Charlotte Pahl. The company is owned by Pharma Equity Group A/S. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -6,570,000 compared with DKK -11,943,000 the year before. Equity in the 2025 report amounted to DKK 4,645,000.